Avelo
Latest round
- Seed
Last raised
- Sep 2022
Total raised
- $2.2M
Investors
- 4
About Avelo
Based in Switzerland, and co-founded in 2020 by Melanie Aregger (CEO), Tobias Broger (CTO), Avelo Inc. is a manufacturer of clinical equipment for treating respiratory infections. In December 2023, Avelo Inc. The firm provides a breath aerosol medical device equipment, AveloCollect, that detects respiratory tract infections causing pneumonia. AveloCollect works with molecular tests and can be used in every healthcare setting. It also reduces over 65% of unnecessary antibiotic prescriptions in primary care by combining respiratory multiplex tests that distinguish between viral and bacterial illnesses.
Who invested in Avelo
4 investors across 1 round
See all investors in Avelo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 20, 2022
Amount
$2.2M
Investors
Questions about Avelo
Who invested in Avelo?
Avelo has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avelo raised?
Avelo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Avelo last raise money?
Avelo's most recent round on record is a Seed, in Sep 2022.
What does Avelo do?
Based in Switzerland, and co-founded in 2020 by Melanie Aregger (CEO), Tobias Broger (CTO), Avelo Inc.
Where is Avelo headquartered?
Avelo is headquartered in Switzerland.
Which VCs invest in companies like Avelo?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Avelo's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Avelo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.